Cargando…
Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study
Combined clinical pretest probability (PTP) and D-dimer testing have great diagnostic value for pulmonary embolism exclusion. To harmonize performance levels of D-dimer assays available on the market, the Clinical and Laboratory Standard Institute (CLSI) has published a guideline, endorsed by the US...
Autores principales: | Pernod, Gilles, Wu, Haifeng, de Maistre, Emmanuel, Lazarchick, John, Kassis, Jeannine, Aguilar, Carlos, Vera, Pascual M., Palareti, Gualtiero, D’Angelo, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407630/ https://www.ncbi.nlm.nih.gov/pubmed/27428016 http://dx.doi.org/10.1097/MBC.0000000000000591 |
Ejemplares similares
-
Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study
por: Aguilar, Carlos, et al.
Publicado: (2018) -
D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?
por: Pernod, Gilles, et al.
Publicado: (2017) -
Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
por: Verma, Karan, et al.
Publicado: (2017) -
Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
por: Palareti, Gualtiero
Publicado: (2012) -
Latest results of diffractive and exclusive measurements with CMS
por: Bylinkin, Alexandr
Publicado: (2018)